Latest Insights on MU

recipe for investing volatile market The Perfect Recipe for a Volatile Market December 1, 2021 by Clint Lee Big Picture. Big Profits., Investing, Trading Strategies Now, anyone who enjoys toiling in the kitchen has their favorite foods. For me, just about any Cajun dish will do. And in the world of Cajun cooking, you quickly learn that the “holy trinity” of onion, bell pepper and celery are the foundation for many recipes. In the same way, you need that trinity — that backbone — for a solid foundation that underpins your investment outlook. You’re in luck. You might not get to taste any of my Cajun dishes soon, but I can give you that investment foundation...
December's Market Outlook: Buy the Omicron Dip! December’s Market Outlook: Buy the Omicron Dip! December 1, 2021 by Chris Cimorelli Monthly Market Outlook, Trading Strategies, True Options Masters In the last Monthly Market Outlook of the year, your True Options Masters share actionable trade ideas to buy the omicron dip!
Hold on, roller coaster omicron market correction main image Omicron’s Market Madness, Meta’s Gif Horse & Raptor’s Wreckage November 30, 2021 by Joseph Hargett Great Stuff Don’t Panic & Carry A Towel The market gets to the bottom then goes back to the top of the slide, where it stops and it turns and it goes for a ride … ‘till it gets to the bottom and it does it again! Yeah, yeah, yeah! Do you, don’t you want me to […]
2022 investing predictions 2 Major Predictions for 2022 November 30, 2021 by Steve Fernandez Investment Opportunities, Winning Investor Daily Looking forward to 2022, I have two major predictions.
omicron Adagio Therapeutics A Stock-Picking Mutation to Beat the Omicron Threat November 30, 2021 by Ted Bauman Big Picture. Big Profits., Global Economy, News This is a company that has never made a profit. In fact, it’s never made any money at all. On top of that, analysts expect its per-share losses to double by the end of 2022. Assuming Adagio manages to generate some revenues next year — the market consensus is a minuscule $151 million — it’s already trading at almost 20 times those sales. Why? Because COVID is here to stay … and the search for a response is moving into new areas … quickly.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

“Loving the 238% gain after I bought your recommendation in Sept. 2019! This week (July 21, 2020) will be my 1 year anniversary with your amazing team … thanks for the life-changing work you all do! Between all your services, 14 triple-digit gains, the greatest at 358%!"

- Matt

“I'm very Happy with your services. I hope you don't plan to retire any time soon! My retirement portfolio depends on your expert guidance. Keep up the great work! Thanks.”

- Randy

“Looks like I have finally found the right person to learn and grow from.”

- James

Share This